个性化,精确的医学治疗阿尔茨海默氏症痴呆症:方法#1
1Clinical Medicine, Department of Medicine, University of California, 2069 Filbert Street, San Francisco, CA 94123, USA.
International journal of molecular sciences
|April 13, 2024
概括
这项研究提出了一种新的连续三重药物疗法,以解决所有18种已知的阿尔茨海默氏症痴呆症 (AD) 的原因,旨在治愈这种疾病. 临床试验将评估2.5年和5.0年的治疗疗效和安全性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 老年学是指老年学的学科.
背景情况:
- 阿尔茨海默氏症痴呆症 (AD) 缺乏确定的治疗方法,目前的治疗方法专注于症状管理.
- 识别AD的个别因果因素是具有挑战性的,阻碍了个性化治疗方法.
- 一项综合性审查确定了18个主要因果因素和29种潜在的AD药物.
研究的目的:
- 为阿尔茨海默氏症痴呆症 (AD) 提出一种新的,个性化的治疗策略,旨在实现治愈.
- 调查连续的三重药物组合的潜力,以解决AD的所有已识别的因果因素.
- 概述一个随机临床试验设计,用于评估建议的AD治疗方案.
主要方法:
- 文献审查以确定AD的因果因素和相应的药物.
- 开发连续的三重药物联合治疗方案.
- 建议进行随机临床试验,持续时间为2.5年和5.0年,以评估安全性和有效性.
主要成果:
- 建议连续使用三重药物组合来解决所有18个已识别的AD因果因素.
- 建议治疗时间为2.5年 (每组合13周) 或5.0年 (每组合26周).
- 建议同时治疗并发性风险因素,并配合连续的药物组合.
结论:
- 连续的三重药物治疗为个性化,精确的医学策略提供了一个有希望的方法,以潜在地治愈阿尔茨海默氏症痴呆症.
- 随机临床试验对于验证这种拟议治疗方案的安全性和有效性至关重要.
- 进一步的研究,包括动物研究,表明更短的治疗时间也可能有效地恢复神经功能.
更多相关视频
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
2.0K
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.0K
相关概念视频
01:22Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:26Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
01:30Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113